Jose Garcia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jose Garcia has a total of 157 co-authors. Here are the top co-authors by number of shared publications:
- Christos Davatzikos
Artificial Intelligence in Biomedical Imaging Laboratory (AIBIL), Center for AI and Data Science for Integrated Diagnostics (AI2D), Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
5 shared publications - MacLean Pancoast Nasrallah
Glioblastoma Translational Center of Excellence, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
3 shared publications - Ashish Singh
Center for Biomedical Image Computing and Analytics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
2 shared publications - Chaitra Badve
Department of Radiology University Hospitals Cleveland Medical Center Cleveland Ohio USA
2 shared publications - Delaire Fattah
Cancer Genetics and Prevention Program, University of California San Francisco, San Francisco, CA
2 shared publications - Edwin A. Alvarez
University of California, San Francisco 2 Helen Diller Family Comprehensive Cancer Center San Francisco, California
2 shared publications
Latest Publications
- Open Access
Structural Brain Networks and the Seizure-Survival Paradox in Glioblastoma
Background: In glioblastoma, tumor-related epilepsy (TRE) is paradoxically associated with longer survival, but the mechanism is unclear. We hypothesized that structural connectivity is associated with seizure susceptibility and survival, and tested whether these associations are independent or mediated. Methods: We retrospectively studied glioblastoma patients with preoperative diffusion-weighted MRI. Fractional anisotropy-weighted connectivity matrices were constructed using lesion-aware tractography. Mean edge weight and local efficiency were computed per Yeo 7-network and with global efficiency at hemisphere and whole-brain levels. Associations with TRE, overall survival (OS), and progression-free survival (PFS) were assessed using logistic regression and Cox proportional hazards models with false discovery rate correction. Causal mediation analysis tested whether connectivity and TRE mediate each other’s relationship with overall survival. Results: We included 420 glioblastoma patients. Of 406 classifiable for TRE, 217 (53%) had TRE. TRE was associated with higher local efficiency across all seven contralateral networks ( d= 0.42-0.49, q< 0.010) and five of seven ipsilateral networks ( d =0.44-0.49, q< 0.050). In adjusted models, higher contralateral global efficiency was associated with longer OS (HR 0.84, q= 0.021), with no metric associated with PFS. TRE did not mediate the connectivity-OS relationship. Contralateral local efficiency partially mediated the TRE-OS association when postoperative KPS was excluded from the model (ACME 16.6 days, 7.8% mediated, p =0.029), though this was attenuated when KPS was included ( p =0.074). Conclusions: Structural connectivity may partially mediate the seizure-survival association, suggesting preserved network architecture may contribute to longer survival in glioblastoma patients with TRE, though most of the effect operates through other pathways. Key Points: Tumor-related epilepsy in glioblastoma was associated with relatively greater structural connectivity. Higher contralateral global efficiency related to longer overall survival. Contralateral local efficiency may partly mediate the seizure-survival link. Importance of the Study: Seizures in glioblastoma are paradoxically associated with longer survival, yet the biological basis of this relationship has remained unknown. Using lesion-aware diffusion tractography in 420 patients, we found that the same structural network measures relate to both seizure susceptibility and survival. Patients with tumor-related epilepsy had relatively greater white matter connectivity, and higher contralateral connectivity was independently associated with longer overall survival. Causal mediation analysis showed that connectivity accounted for a small fraction of the seizure-survival association, suggesting that seizures mark, rather than confer, the survival advantage, and that both may reflect a shared upstream driver not captured here. These findings identify structural connectivity as a shared correlate and candidate imaging biomarker for seizure risk and prognosis in glioblastoma.
Open AccessStructural Brain Networks and the Seizure-Survival Paradox in Glioblastoma
Background: In glioblastoma, tumor-related epilepsy (TRE) is paradoxically associated with longer survival, but the mechanism is unclear. We hypothesized that structural connectivity is associated with seizure susceptibility and survival, and tested whether these associations are independent or mediated. Methods: We retrospectively studied glioblastoma patients with preoperative diffusion-weighted MRI. Fractional anisotropy-weighted connectivity matrices were constructed using lesion-aware tractography. Mean edge weight and local efficiency were computed per Yeo 7-network and with global efficiency at hemisphere and whole-brain levels. Associations with TRE, overall survival (OS), and progression-free survival (PFS) were assessed using logistic regression and Cox proportional hazards models with false discovery rate correction. Causal mediation analysis tested whether connectivity and TRE mediate each other’s relationship with overall survival. Results: We included 420 glioblastoma patients. Of 406 classifiable for TRE, 217 (53%) had TRE. TRE was associated with higher local efficiency across all seven contralateral networks ( d= 0.42-0.49, q< 0.010) and five of seven ipsilateral networks ( d =0.44-0.49, q< 0.050). In adjusted models, higher contralateral global efficiency was associated with longer OS (HR 0.84, q= 0.021), with no metric associated with PFS. TRE did not mediate the connectivity-OS relationship. Contralateral local efficiency partially mediated the TRE-OS association when postoperative KPS was excluded from the model (ACME 16.6 days, 7.8% mediated, p =0.029), though this was attenuated when KPS was included ( p =0.074). Conclusions: Structural connectivity may partially mediate the seizure-survival association, suggesting preserved network architecture may contribute to longer survival in glioblastoma patients with TRE, though most of the effect operates through other pathways. Key Points: Tumor-related epilepsy in glioblastoma was associated with relatively greater structural connectivity. Higher contralateral global efficiency related to longer overall survival. Contralateral local efficiency may partly mediate the seizure-survival link. Importance of the Study: Seizures in glioblastoma are paradoxically associated with longer survival, yet the biological basis of this relationship has remained unknown. Using lesion-aware diffusion tractography in 420 patients, we found that the same structural network measures relate to both seizure susceptibility and survival. Patients with tumor-related epilepsy had relatively greater white matter connectivity, and higher contralateral connectivity was independently associated with longer overall survival. Causal mediation analysis showed that connectivity accounted for a small fraction of the seizure-survival association, suggesting that seizures mark, rather than confer, the survival advantage, and that both may reflect a shared upstream driver not captured here. These findings identify structural connectivity as a shared correlate and candidate imaging biomarker for seizure risk and prognosis in glioblastoma.
- Open Access
- 13 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Personalized machine learning-guided radiation dose escalation in newly diagnosed glioblastoma: prospective pilot study
Glioblastoma is a highly aggressive primary brain tumor with near-universal recurrence despite maximal safe resection followed by standard chemoradiation. We conducted a prospective pilot study (ClinicalTrials.gov identifier: NCT03477513) with predefined endpoints and structured dose-escalation criteria to evaluate the feasibility and safety of personalized precision radiation therapy (PPRT) guided by machine learning (ML)-based maps of tumor infiltration. Twenty patients with newly diagnosed IDH-wildtype glioblastoma who underwent gross total resection received PPRT with concomitant and adjuvant temozolomide. The primary outcomes were median progression-free survival (PFS) and safety. Secondary outcomes included patterns of recurrence, rate of clinically significant toxicity, and median overall survival (OS). PPRT was feasible and well tolerated, with no grade ≥3 acute adverse events; 47% experienced grade 1 and 53% grade 2 events. Following therapy, radiation necrosis occurred in 47% of PPRT-temozolomide patients versus 12% in standard-of-care patients (p < 0.001). Median PFS was 24.4 months versus 11.6 months in 68 propensity score matched (PSM) historical control group (HR 0.28, 95% CI 0.13-0.61; p = 0.001). Median OS was 35.4 versus 17.7 months (HR 0.34, 95% CI 0.17-0.69; p = 0.003). Exploratory post hoc comparison suggests improved survival, but these findings are preliminary and require validation in randomized trials.
- 13 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessPersonalized machine learning-guided radiation dose escalation in newly diagnosed glioblastoma: prospective pilot study
Glioblastoma is a highly aggressive primary brain tumor with near-universal recurrence despite maximal safe resection followed by standard chemoradiation. We conducted a prospective pilot study (ClinicalTrials.gov identifier: NCT03477513) with predefined endpoints and structured dose-escalation criteria to evaluate the feasibility and safety of personalized precision radiation therapy (PPRT) guided by machine learning (ML)-based maps of tumor infiltration. Twenty patients with newly diagnosed IDH-wildtype glioblastoma who underwent gross total resection received PPRT with concomitant and adjuvant temozolomide. The primary outcomes were median progression-free survival (PFS) and safety. Secondary outcomes included patterns of recurrence, rate of clinically significant toxicity, and median overall survival (OS). PPRT was feasible and well tolerated, with no grade ≥3 acute adverse events; 47% experienced grade 1 and 53% grade 2 events. Following therapy, radiation necrosis occurred in 47% of PPRT-temozolomide patients versus 12% in standard-of-care patients (p < 0.001). Median PFS was 24.4 months versus 11.6 months in 68 propensity score matched (PSM) historical control group (HR 0.28, 95% CI 0.13-0.61; p = 0.001). Median OS was 35.4 versus 17.7 months (HR 0.34, 95% CI 0.17-0.69; p = 0.003). Exploratory post hoc comparison suggests improved survival, but these findings are preliminary and require validation in randomized trials.
- Open Access
- 12 January 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 8 (1)
Poor brain reserve increases mortality risk in glioblastoma
Background: Brain reserve refers to the structural capacity of the brain and correlates with age and Karnofsky Performance Status (KPS). While age and KPS are known independent predictors of survival in glioblastoma patients, the role of brain reserve in influencing glioblastoma outcomes remains unexplored. This study investigates the relationship between baseline brain-reserve metrics and survival outcomes in isocitrate dehydrogenase 1-wildtype (IDH1-WT) glioblastoma. Methods: We analyzed 841 patients with IDH1-WT glioblastoma using clinical data and presurgical MR images sourced from 4 institutions. MRI-based tumor characteristics and quantitative brain-reserve metrics were assessed using the Cancer Imaging Phenomics Toolkit and the Computational Anatomy Toolbox. Statistical and survival analyses were conducted using MATLAB and R. Results: Long-term survivors showed significantly higher residual functional gray matter volume (rfGM) (P < .001), gyrification (P = .001), and cortical thickness (P < .001) compared to medium- and short-term survivors. Multivariable Cox analysis indicated significant associations between rfGM (P < .001) and gyrification (P = .008) with mortality after adjusting for clinical variables except age and KPS. After controlling for all clinical variables including age and KPS, gyrification (P = .01), sulcal depth (P = .02), and cortical thickness (P = .005) were significantly associated with mortality. Conclusion: This multi-institutional study establishes significant associations between structural brain-reserve metrics and glioblastoma outcomes, independent of age and KPS. The findings highlight the potential of brain reserve as a new biomarker for brain tumor prognosis and treatment planning.
- 12 January 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 8 (1)
Open AccessPoor brain reserve increases mortality risk in glioblastoma
Background: Brain reserve refers to the structural capacity of the brain and correlates with age and Karnofsky Performance Status (KPS). While age and KPS are known independent predictors of survival in glioblastoma patients, the role of brain reserve in influencing glioblastoma outcomes remains unexplored. This study investigates the relationship between baseline brain-reserve metrics and survival outcomes in isocitrate dehydrogenase 1-wildtype (IDH1-WT) glioblastoma. Methods: We analyzed 841 patients with IDH1-WT glioblastoma using clinical data and presurgical MR images sourced from 4 institutions. MRI-based tumor characteristics and quantitative brain-reserve metrics were assessed using the Cancer Imaging Phenomics Toolkit and the Computational Anatomy Toolbox. Statistical and survival analyses were conducted using MATLAB and R. Results: Long-term survivors showed significantly higher residual functional gray matter volume (rfGM) (P < .001), gyrification (P = .001), and cortical thickness (P < .001) compared to medium- and short-term survivors. Multivariable Cox analysis indicated significant associations between rfGM (P < .001) and gyrification (P = .008) with mortality after adjusting for clinical variables except age and KPS. After controlling for all clinical variables including age and KPS, gyrification (P = .01), sulcal depth (P = .02), and cortical thickness (P = .005) were significantly associated with mortality. Conclusion: This multi-institutional study establishes significant associations between structural brain-reserve metrics and glioblastoma outcomes, independent of age and KPS. The findings highlight the potential of brain reserve as a new biomarker for brain tumor prognosis and treatment planning.
- Open Access
- 15 November 2025
- Published by Springer Nature in Communications Medicine
- Vol. 5 (1)
Neuroanatomical dimensions in major depression linked to cognition, adverse life events, self-harm, metabolomics and genetics
Background Major depressive disorder (MDD) is a leading cause of disability worldwide, yet its diagnosis relies on clinical symptoms alone. Methods Using the semi-supervised machine learning algorithm, Heterogeneity through Discriminative Analysis (HYDRA), we had identified two neuroanatomical dimensions in deeply phenotyped (i.e., comprehensively assessed across neuroimaging, clinical, and behavioural domains), medication-free participants with MDD from the COORDINATE-MDD consortium. In the present study, we apply this pre-trained HYDRA model to the UK Biobank (UKB) to validate these dimensions in a large general population and a subsample with current depressive symptoms. Results Dimension 2 (D2), compared to Dimension 1 (D1), is characterized by reduced grey and white matter volumes and limited treatment response to antidepressant and placebo medications. Out-of-sample validation in the UKB general population (n = 37,235) confirms these neuroanatomical features and reveals D2 associations with cognitive impairments, adverse life events, self-harm and suicide attempts, a pro-atherogenic lipid profile, and genetic links to neurodegenerative traits. Similar profiles are observed in the UKB subsample with current depressive symptoms (n = 1455). Conclusions D1 and D2 represent distinct neurobiological mechanisms underlying MDD. The validation in a general population-based cohort and in a cohort sample with depressive symptoms delineates mechanisms underlying heterogeneity in MDD.
- 15 November 2025
- Published by Springer Nature in Communications Medicine
- Vol. 5 (1)
Open AccessNeuroanatomical dimensions in major depression linked to cognition, adverse life events, self-harm, metabolomics and genetics
Background Major depressive disorder (MDD) is a leading cause of disability worldwide, yet its diagnosis relies on clinical symptoms alone. Methods Using the semi-supervised machine learning algorithm, Heterogeneity through Discriminative Analysis (HYDRA), we had identified two neuroanatomical dimensions in deeply phenotyped (i.e., comprehensively assessed across neuroimaging, clinical, and behavioural domains), medication-free participants with MDD from the COORDINATE-MDD consortium. In the present study, we apply this pre-trained HYDRA model to the UK Biobank (UKB) to validate these dimensions in a large general population and a subsample with current depressive symptoms. Results Dimension 2 (D2), compared to Dimension 1 (D1), is characterized by reduced grey and white matter volumes and limited treatment response to antidepressant and placebo medications. Out-of-sample validation in the UKB general population (n = 37,235) confirms these neuroanatomical features and reveals D2 associations with cognitive impairments, adverse life events, self-harm and suicide attempts, a pro-atherogenic lipid profile, and genetic links to neurodegenerative traits. Similar profiles are observed in the UKB subsample with current depressive symptoms (n = 1455). Conclusions D1 and D2 represent distinct neurobiological mechanisms underlying MDD. The validation in a general population-based cohort and in a cohort sample with depressive symptoms delineates mechanisms underlying heterogeneity in MDD.
- 29 April 2024
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 45 (9) , 1299-1307
Sex-Specific Differences in Patients withIDH1–Wild-Type Grade 4 Glioma in the ReSPOND Consortium
Background: Understanding sex-based differences in glioblastoma patients is necessary for accurate personalized treatment planning to improve patient outcomes. Purpose: To investigate sex-specific differences in molecular, clinical and radiological tumor parameters, as well as survival outcomes in glioblastoma, isocitrate dehydrogenase-1 wildtype (IDH1-WT), grade 4 patients. Methods: Retrospective data of 1832 glioblastoma, IDH1-WT patients with comprehensive information on tumor parameters was acquired from the Radiomics Signatures for Precision Oncology in Glioblastoma (ReSPOND) consortium. Data imputation was performed for missing values. Sex-based differences in tumor parameters, such as, age, molecular parameters, pre-operative KPS score, tumor volumes, epicenter and laterality were assessed through non-parametric tests. Spatial atlases were generated using pre-operative MRI maps to visualize tumor characteristics. Survival time analysis was performed through log-rank tests and Cox proportional hazard analyses. Results: GBM was diagnosed at a median age of 64 years in females compared to 61.9 years in males (FDR = 0.003). Males had a higher Karnofsky Performance Score (above 80) as compared to females (60.4% females Vs 69.7% males, FDR = 0.044). Females had lower tumor volumes in enhancing (16.7 cm3 Vs. 20.6 cm3 in males, FDR = 0.001), necrotic core (6.18 cm3 Vs. 7.76 cm3 in males, FDR = 0.001) and edema regions (46.9 cm3 Vs. 59.2 cm3 in males, FDR = 0.0001). Right temporal region was the most common tumor epicenter in the overall population. Right as well as left temporal lobes were more frequently involved in males. There were no significant differences in survival outcomes and mortality ratios. Higher age, unmethylated O6-methylguanine-DNAmethyltransferase (MGMT) promoter and undergoing subtotal resection increased the mortality risk in both males and females. Conclusions: Our study demonstrates significant sex-based differences in clinical and radiological tumor parameters of glioblastoma, IDH1-WT, grade 4 patients. Sex is not an independent prognostic factor for survival outcomes and the tumor parameters influencing patient outcomes are identical for males and females. ABBREVIATIONS: IDH1-WT = isocitrate dehydrogenase-1 wildtype; MGMTp = O6-methylguanine-DNA-methyltransferase promoter; KPS = Karnofsky performance score; EOR = extent of resection; WHO = world health organization; FDR = false discovery rate
- 29 April 2024
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 45 (9) , 1299-1307
Sex-Specific Differences in Patients withIDH1–Wild-Type Grade 4 Glioma in the ReSPOND Consortium
Background: Understanding sex-based differences in glioblastoma patients is necessary for accurate personalized treatment planning to improve patient outcomes. Purpose: To investigate sex-specific differences in molecular, clinical and radiological tumor parameters, as well as survival outcomes in glioblastoma, isocitrate dehydrogenase-1 wildtype (IDH1-WT), grade 4 patients. Methods: Retrospective data of 1832 glioblastoma, IDH1-WT patients with comprehensive information on tumor parameters was acquired from the Radiomics Signatures for Precision Oncology in Glioblastoma (ReSPOND) consortium. Data imputation was performed for missing values. Sex-based differences in tumor parameters, such as, age, molecular parameters, pre-operative KPS score, tumor volumes, epicenter and laterality were assessed through non-parametric tests. Spatial atlases were generated using pre-operative MRI maps to visualize tumor characteristics. Survival time analysis was performed through log-rank tests and Cox proportional hazard analyses. Results: GBM was diagnosed at a median age of 64 years in females compared to 61.9 years in males (FDR = 0.003). Males had a higher Karnofsky Performance Score (above 80) as compared to females (60.4% females Vs 69.7% males, FDR = 0.044). Females had lower tumor volumes in enhancing (16.7 cm3 Vs. 20.6 cm3 in males, FDR = 0.001), necrotic core (6.18 cm3 Vs. 7.76 cm3 in males, FDR = 0.001) and edema regions (46.9 cm3 Vs. 59.2 cm3 in males, FDR = 0.0001). Right temporal region was the most common tumor epicenter in the overall population. Right as well as left temporal lobes were more frequently involved in males. There were no significant differences in survival outcomes and mortality ratios. Higher age, unmethylated O6-methylguanine-DNAmethyltransferase (MGMT) promoter and undergoing subtotal resection increased the mortality risk in both males and females. Conclusions: Our study demonstrates significant sex-based differences in clinical and radiological tumor parameters of glioblastoma, IDH1-WT, grade 4 patients. Sex is not an independent prognostic factor for survival outcomes and the tumor parameters influencing patient outcomes are identical for males and females. ABBREVIATIONS: IDH1-WT = isocitrate dehydrogenase-1 wildtype; MGMTp = O6-methylguanine-DNA-methyltransferase promoter; KPS = Karnofsky performance score; EOR = extent of resection; WHO = world health organization; FDR = false discovery rate
- Open Access
- 26 March 2024
- Published by Akademiai Kiado Zrt. in Journal of Behavioral Addictions
- Vol. 13 (1) , 276-292
Mental health professionals' use of the ICD-11 classification of impulse control disorders and behavioral addictions: An international field study
Background and aims: The ICD-11 chapter on mental, behavioral and neurodevelopmental disorders contains new controversial diagnoses including compulsive sexual behavior disorder (CSBD), intermittent explosive disorder (IED) and gaming disorder. Using a vignette-based methodology, this field study examined the ability of mental health professionals (MHPs) to apply the new ICD-11 diagnostic requirements for impulse control disorders, which include CSBD and IED, and disorders due to addictive behaviors, which include gaming disorder, compared to the previous ICD-10 guidelines.Methods: Across eleven comparisons, members of the WHO's Global Clinical Practice Network (N = 1,090) evaluated standardized case descriptions that were designed to test key differences between the diagnostic guidelines of ICD-11 and ICD-10.Results: The ICD-11 outperformed the ICD-10 in the accuracy of diagnosing impulse control disorders and behavioral addictions in most comparisons, while the ICD-10 was not superior in any. The superiority of the ICD-11 was particularly clear where new diagnoses had been added to the classification system or major revisions had been made. However, the ICD-11 outperformed the ICD-10 only in a minority of comparisons in which mental health professionals were asked to evaluate cases with non-pathological high involvement in rewarding behaviors.Discussion and Conclusions: Overall, the present study indicates that the ICD-11 diagnostic requirements represent an improvement over the ICD-10 guidelines. However, additional efforts, such as training programs for MHPs and possible refinements of diagnostic guidance, are needed to avoid over-diagnosis of people who are highly engaged in a repetitive and rewarding behavior but below the threshold for a disorder.
- 26 March 2024
- Published by Akademiai Kiado Zrt. in Journal of Behavioral Addictions
- Vol. 13 (1) , 276-292
Open AccessMental health professionals' use of the ICD-11 classification of impulse control disorders and behavioral addictions: An international field study
Background and aims: The ICD-11 chapter on mental, behavioral and neurodevelopmental disorders contains new controversial diagnoses including compulsive sexual behavior disorder (CSBD), intermittent explosive disorder (IED) and gaming disorder. Using a vignette-based methodology, this field study examined the ability of mental health professionals (MHPs) to apply the new ICD-11 diagnostic requirements for impulse control disorders, which include CSBD and IED, and disorders due to addictive behaviors, which include gaming disorder, compared to the previous ICD-10 guidelines.Methods: Across eleven comparisons, members of the WHO's Global Clinical Practice Network (N = 1,090) evaluated standardized case descriptions that were designed to test key differences between the diagnostic guidelines of ICD-11 and ICD-10.Results: The ICD-11 outperformed the ICD-10 in the accuracy of diagnosing impulse control disorders and behavioral addictions in most comparisons, while the ICD-10 was not superior in any. The superiority of the ICD-11 was particularly clear where new diagnoses had been added to the classification system or major revisions had been made. However, the ICD-11 outperformed the ICD-10 only in a minority of comparisons in which mental health professionals were asked to evaluate cases with non-pathological high involvement in rewarding behaviors.Discussion and Conclusions: Overall, the present study indicates that the ICD-11 diagnostic requirements represent an improvement over the ICD-10 guidelines. However, additional efforts, such as training programs for MHPs and possible refinements of diagnostic guidance, are needed to avoid over-diagnosis of people who are highly engaged in a repetitive and rewarding behavior but below the threshold for a disorder.
- Open Access
- 1 August 2020
- Published by Clemson University in Journal of Extension
- Vol. 58 (4) , 17
Improving Parental Engagement for Latino Youths' Educational Success: Lessons from Juntos Oregon
Research has shown that more efforts are needed to increase high school completion and postsecondary enrollment among Latino youths. However, little is known regarding efforts that engage both Latino youths and their parents. To address this gap, we surveyed Juntos Oregon participants to examine the school and community context Latino youths and their families face in the educational journey and identify effects of the Juntos program. Results showed that in a context of persistent discrimination and unfair treatment, Juntos workshops increased the sense of school and community connectedness among Latino parents. Increases in academic planning and motivation occurred as well. Extension may increase its educational impact by strengthening connections and promoting engagement between schools and Latino families.
- 1 August 2020
- Published by Clemson University in Journal of Extension
- Vol. 58 (4) , 17
Open AccessImproving Parental Engagement for Latino Youths' Educational Success: Lessons from Juntos Oregon
Research has shown that more efforts are needed to increase high school completion and postsecondary enrollment among Latino youths. However, little is known regarding efforts that engage both Latino youths and their parents. To address this gap, we surveyed Juntos Oregon participants to examine the school and community context Latino youths and their families face in the educational journey and identify effects of the Juntos program. Results showed that in a context of persistent discrimination and unfair treatment, Juntos workshops increased the sense of school and community connectedness among Latino parents. Increases in academic planning and motivation occurred as well. Extension may increase its educational impact by strengthening connections and promoting engagement between schools and Latino families.
- Open Access
Alcohol consumption in Spanish primary health care providers: a national, cross-sectional study
Aim To estimate the prevalence of alcohol consumption and analyse the drinking patterns among primary healthcare (PHC) providers. Design Observational, cross-sectional, descriptive study. Setting PHC centres in the Spanish National Health System (SNHS). Participants Doctors and nurses who completed an online questionnaire which explored their alcohol intake, using the Alcohol Use Disorders Identification Test (AUDIT-C) alcohol assessment tool. The study population was recruited by random sampling stratified by regions of the SNHS PHC centres. Primary and secondary outcome measures Frequency of alcohol consumption, number of alcohol drinks on a typical day, frequency of more than six standard drinks (SDs) intake. Results A total of 1760 PHC providers completed the questionnaire. The frequency of alcohol consumption was: abstention (12%, 95% CI 10.4% to 13.5%); one or less SDs/month (26%, 95% CI 23.8% to 27.9%); 2–4 SDs/month (32.2%, 95% CI 29.7% to 34.1%); 2–3 SDs/week (17.9%, 95% CI 16.0% to 19.6%); four or more SDs/week (11.9%, 95% CI 10.3% to 13.3%). The number of drinks on a typical day was: none (45.6%, 95% CI 42.9% to 47.6%); 1–2 drinks (47.3%, 95% CI 23.8% to 27.9%); 3–4 drinks (6.5%, 95% CI 5.3% to 7.6%). The percentage of hazardous drinking, according to AUDIT-C criteria, was 32% (95% CI 26.7 to 37.3), with a greater frequency of intake in older professionals (pConclusions Our study discloses the most up-to-date portrait of current alcohol consumption among Spanish PHC providers, showing a higher prevalence of alcohol intake, compared with the general population. Preventive strategies should be implemented to improve the awareness and training of PHC professionals towards alcohol consumption.
Open AccessAlcohol consumption in Spanish primary health care providers: a national, cross-sectional study
Aim To estimate the prevalence of alcohol consumption and analyse the drinking patterns among primary healthcare (PHC) providers. Design Observational, cross-sectional, descriptive study. Setting PHC centres in the Spanish National Health System (SNHS). Participants Doctors and nurses who completed an online questionnaire which explored their alcohol intake, using the Alcohol Use Disorders Identification Test (AUDIT-C) alcohol assessment tool. The study population was recruited by random sampling stratified by regions of the SNHS PHC centres. Primary and secondary outcome measures Frequency of alcohol consumption, number of alcohol drinks on a typical day, frequency of more than six standard drinks (SDs) intake. Results A total of 1760 PHC providers completed the questionnaire. The frequency of alcohol consumption was: abstention (12%, 95% CI 10.4% to 13.5%); one or less SDs/month (26%, 95% CI 23.8% to 27.9%); 2–4 SDs/month (32.2%, 95% CI 29.7% to 34.1%); 2–3 SDs/week (17.9%, 95% CI 16.0% to 19.6%); four or more SDs/week (11.9%, 95% CI 10.3% to 13.3%). The number of drinks on a typical day was: none (45.6%, 95% CI 42.9% to 47.6%); 1–2 drinks (47.3%, 95% CI 23.8% to 27.9%); 3–4 drinks (6.5%, 95% CI 5.3% to 7.6%). The percentage of hazardous drinking, according to AUDIT-C criteria, was 32% (95% CI 26.7 to 37.3), with a greater frequency of intake in older professionals (pConclusions Our study discloses the most up-to-date portrait of current alcohol consumption among Spanish PHC providers, showing a higher prevalence of alcohol intake, compared with the general population. Preventive strategies should be implemented to improve the awareness and training of PHC professionals towards alcohol consumption.